Skip to content
Screener

Common Stock at other companies

EyePoint, Inc. logo
EyePoint, Inc.EYPT
$85K+23.2%
KLR
Kalaris TherapeuticsKLRS
$2K0.0%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$5K0.0%
HRO
HarrowHROW
50M0.0%
PVL
Palvella TherapeuticsPVLA
$14K+27.3%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
450M0.0%

Other financials

Income statement

See full
Operating income-$59.8M-1.2%
Net income-$58.2M-1.2%
EPS (diluted)-$0.94+13.8%

Balance sheet

See full
Cash & equivalents$169.5M+22.1%
Total debt$56.0M-17.2%
Total equity$112.1M+3.0%
Total assets$306.0M+2.7%

Cash flow

See full
Operating cash flow-$40.0M-37.6%
CapEx$942.0K+249%
Free cash flow-$41.0M-39.5%

Valuation

See full
Market cap$2.84B+556%
Enterprise value$2.73B+592%

Returns & leverage

See full
Return on equity-208.8%+2,306pp
Debt / equity0.5×-0.1×
Current ratio3.5×-1.1×

Where this comes from

Reported directly by Kodiak Sciences Inc in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The source filing: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-211951
Line itemMarch 31,2026December 31,2025
Commitments and contingencies (Note 5)
Stockholders’ equity:
Preferred stock, $0.0001 par value – 10,000,000 shares authorized;none issued
Common stock, $0.0001 par value – 490,000,000 shares authorized; 62,155,685 and 61,758,454 shares issued and outstanding, respectively66
Additional paid-in capital1,728,9581,716,082
Accumulated deficit(1,616,863)(1,558,705)
Total stockholders’ equity112,101157,383
Total liabilities and stockholders’ equity$306,006$351,533

Item 1. Financial Statements (Unaudited).

FAQ

What is Kodiak Sciences Inc's common stock?
Kodiak Sciences Inc (KOD) reported common stock of $6K in Q1 2026.
How has Kodiak Sciences Inc's common stock changed year-over-year?
Kodiak Sciences Inc's common stock increased by 20.0% year-over-year, from $5K to $6K.
What is the long-term trend for Kodiak Sciences Inc's common stock?
Over 5 years (2020 to 2025), Kodiak Sciences Inc's common stock has grown at a 3.7% compound annual growth rate (CAGR), from $5K to $6K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Ask your AI about Kodiak Sciences Inc's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude